These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12492784)

  • 1. Vascular dementia: galantamine (Reminyl) as an emerging therapeutic option.
    Small GW
    Acta Neurol Scand Suppl; 2002; 178():4-5. PubMed ID: 12492784
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of reminyl (galantamine) in the treatment of probable vascular dementia].
    Mokhova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):77-9. PubMed ID: 19911468
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of galantamine to treat vascular dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Lancet; 2002 Nov; 360(9344):1512-3; author reply 1513. PubMed ID: 12433549
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of galantamine to treat vascular dementia.
    van Gool WA
    Lancet; 2002 Nov; 360(9344):1512; author reply 1513. PubMed ID: 12433548
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementia.
    Kurz A
    Acta Neurol Scand Suppl; 2002; 178():19-24. PubMed ID: 12492788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options: the latest evidence with galantamine (Reminyl).
    Erkinjuntti T
    J Neurol Sci; 2002 Nov; 203-204():125-30. PubMed ID: 12417370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Traditional dementia concepts in transition--must we change our views?].
    Nervenarzt; 2005 Sep; 76(9):2p following 1164. PubMed ID: 16320378
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive decline and treatment options for patients with vascular dementia.
    Erkinjuntti T
    Acta Neurol Scand Suppl; 2002; 178():15-8. PubMed ID: 12492787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].
    Gavrilova SI; Zharikov GA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):59-65. PubMed ID: 14763262
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment--How to treat vascular dementia?
    Bonelli RM
    Stroke; 2003 Oct; 34(10):2331-2. PubMed ID: 14500926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of reminyl (galantamine) in the treatment of dementia].
    Voronkova KV; Pylaeva OA; Mazal'skaia OV; Lemeshko ID; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):26-30. PubMed ID: 16608108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
    Sorokina ND; Selitskiĭ GV; Kositsyn NS
    Fiziol Cheloveka; 2007; 33(3):35-9. PubMed ID: 17619614
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI.
    Leijenaar JF; Groeneveld GJ; Klaassen ES; Leeuwis AE; Scheltens P; Weinstein HC; van Gerven JMA; Barkhof F; van der Flier WM; Prins ND
    Alzheimers Res Ther; 2020 Jan; 12(1):10. PubMed ID: 31910895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
    Bowler JV
    Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reminyl efficacy in dementia with Levi bodies].
    Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):15-21. PubMed ID: 16281374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.